Across TCGA pan-cancer cohorts, OR1X5P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR1X5P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR1X5P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR1X5P is over-expressed in tumor.

HNSC, KIRC, and LUSC are the cancer types where OR1X5P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR1X5P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.038	.008	8	view →
KIRC	All	II,III,IV	+0.024	.004	6	view →
LUSC	All	All	+0.012	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR1X5P RNA expression & survival · all OR1X5P data types